Out of all the workout tops we’ve tried over the years, editors agree that the Lululemon Ebb to Street Tank is our favorite.

Lily Allen and David Harbour have reportedly separated after four years of marriage. According to The Sun, the couple broke ...

Lilly Pulitzer’s treasured Sunshine Sale is back with splurge-worthy discounts and new styles perfect for the winter or ...

Put a little sunshine into the cold, gray days of winter with Lilly Pulitzer’s Sunshine Sale. The iconic brand has tons of deals up to 70% off. The sale includes women’s clothing and home goods, all ...

Lily-Rose Depp has revealed which of her dad Johnny Depp’s famous films left her “traumatized” as a child. In a new interview with Harper’s Bazaar, the “Nosferatu” star, 25, said she ...

INDIANAPOLIS (WISH) – The FDA has now approved Lilly’s Zepbound (glp-1 agonist) for sleep apnea. It’s the first medication approved for this condition. Sleep apnea affects 25 million ...

Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...

Lily-Rose Depp was born into Hollywood royalty ... "I just hear it a lot more about women, and I don’t think that it’s a coincidence." Tracy Wright is an entertainment reporter for Fox ...

A recent Mia Khalifa post in which she defended Lily-Rose Depp from criticism has gone viral on social media. Depp, the daughter of actor Johnny Depp and singer, model, and actor Vanessa Paradis ...

so it felt a lot less nerve-wracking,” Lilly added. Sophie Phillips is a 6-foot guard who is rapidly closing in on Rhode Island’s 3-point record for women’s basketball, with 195 in her career.

WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug to get the green light to ...

An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.